Artemis Medicare Services Ltd. (ARTEMISMED) Share Price Hits 52-Week High
- July 29, 2026
- Posted by: Harsh Piplani
- Category: News
Artemis Medicare Services Ltd. Share Price surged to a fresh 52-week high of Rs 305.55, marking a 7.34% increase today. The market cap is Rs 4,408.04 crore.
Artemis Medicare Services Ltd. Share Price has reached a new 52-week high today, trading at Rs 305.55, up 7.34% from the previous close of Rs 277.2. The company’s market capitalisation stands at Rs 4,408.04 crore. This significant price movement highlights investor interest in the stock, although the data does not specify a particular catalyst for this rise. With the healthcare sector’s dynamic landscape, Artemis Medicare’s performance is noteworthy, especially as it surpasses its previous 52-week high.
Artemis Medicare Services Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 297.55 |
| Previous Close | Rs 277.2 |
| Today's Change | +Rs 20.35 (+7.34%) |
| Day Open | Rs 281 |
| Fresh 52-Week High | Rs 305.55 |
| Day Low | Rs 277.1 |
| Current Volume | 63,584 |
| Turnover | Rs 1.89 crore |
| Market Capitalisation | Rs 4,408.04 crore |
Today, Artemis Medicare Services Ltd. opened at Rs 281 and quickly climbed to a high of Rs 305.55, setting a new 52-week peak. The stock closed at Rs 297.55, reflecting a day change of Rs 20.35 or 7.34%. The day’s low was Rs 277.1, with a turnover of Rs 1.89 crore and a volume of 63,584 shares. This price action suggests strong investor engagement, as the stock broke past its previous 52-week high.
Artemis Medicare Services Ltd. (ARTEMISMED) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 4,408.04 crore |
| P/E Ratio | 29.31x |
| P/B Ratio | 0.43x |
| ROE | -2.89% |
| ROCE | -0.26% |
Artemis Medicare Services Ltd. was valued at a P/E ratio of 29.31x, a P/B ratio of 0.43x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 29.31x |
| Benchmark Median P/E | 21.06x |
| Benchmark Average P/E | 68.59x |
| Benchmark P/E Range | 0x to 3,439.3x |
| Company P/B Ratio | 0.43x |
| Benchmark Median P/B | 1.88x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.91% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.2% |
| Company Market Capitalisation | Rs 4,408.04 crore |
| Benchmark Median Market Cap | Rs 140.64 crore |
Artemis Medicare Services Ltd. (ARTEMISMED) is classified under sector: Healthcare. The numerical benchmark uses 198 same sector companies from the supplied master-data set.
Artemis Medicare Services Ltd. (ARTEMISMED) has a P/E ratio of 29.31x, which is above the benchmark median of 21.06x, a difference of +39.17%. The benchmark contains 198 companies with P/E data, ranging from 0x to 3,439.3x. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Artemis Medicare Services Ltd. (ARTEMISMED) has a ROE of -2.89%, which is below the benchmark median of 10.91%, a difference of -126.49%. Artemis Medicare Services Ltd. (ARTEMISMED) has a ROCE of -0.26%, which is below the benchmark median of 13.2%, a difference of -101.97%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,921.65 | 29.31 | 0.43 | -2.89 | -0.26 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,815.27 | 39.89 | 8.12 | 28.21 | 26.35 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,476.69 | 169.37 | 3.13 | 13.9 | 12.97 |
| Beta Drugs Ltd. | BETA | 2,472.93 | 56.38 | 8.92 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,444.35 | 34.87 | 7.06 | -2.6 | 16.92 |
Artemis Medicare Services Ltd. (ARTEMISMED) has a P/E ratio of 29.31x compared with the displayed peer median of 39.89x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Artemis Medicare Services Ltd. (ARTEMISMED) has a market capitalisation of Rs 4,408.04 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Artemis Medicare Services Ltd.
- Artemis Medicare Services Ltd. Share Price reached a new 52-week high, attracting market attention.
- The stock’s P/B ratio suggests potential undervaluation compared to sector benchmarks.
- Despite negative profitability metrics, the company’s market cap indicates significant market presence.
- Investors are monitoring its performance within the competitive healthcare sector.
About Artemis Medicare Services Ltd.
Artemis Medicare Services Ltd. is a prominent player in the healthcare sector, providing a range of medical services. The company operates hospitals and healthcare facilities, offering comprehensive medical care across various specialties. Its strategic focus on quality healthcare and patient satisfaction positions it as a key player in the industry. With a robust infrastructure and experienced medical professionals, Artemis Medicare continues to expand its footprint in the healthcare domain.
Track Artemis Medicare Services Ltd. Share Price on Univest
Use Artemis Medicare Services Ltd. (ARTEMISMED) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors can track Artemis Medicare Services Ltd. Share Price, technical indicators, fundamental ratios, shareholding pattern, 52-week levels, and market insights on Univest for comprehensive analysis and informed decision-making.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current share price of Artemis Medicare Services Ltd.?
Ans. The current share price of Artemis Medicare Services Ltd. is Rs 297.55, following a 7.34% increase today, reaching a fresh 52-week high of Rs 305.55. The stock moved 7.34% during the session.
What is the market capitalisation of Artemis Medicare Services Ltd.?
Ans. The market capitalisation of Artemis Medicare Services Ltd. is Rs 4,408.04 crore, reflecting its substantial presence in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 29.31x.
How does Artemis Medicare Services Ltd.'s P/E ratio compare to the sector?
Ans. Artemis Medicare Services Ltd.'s P/E ratio of 29.31 is higher than the sector median of 21.06 but aligns with the sector's average, indicating competitive valuation. The company trades at a P/E ratio of 29.31x.
What are the profitability metrics of Artemis Medicare Services Ltd.?
Ans. Artemis Medicare Services Ltd. reports a negative ROE of -2.89% and ROCE of -0.26%, suggesting challenges in profitability compared to sector peers. ROE stands at -2.89%. ROCE stands at -0.26%.
How does Artemis Medicare Services Ltd.'s P/B ratio compare to the sector?
Ans. The P/B ratio of Artemis Medicare Services Ltd. is 0.43, significantly lower than the sector median of 1.88, indicating potential undervaluation. The company trades at a P/E ratio of 29.31x.
Who are the peers of Artemis Medicare Services Ltd.?
Ans. Peers of Artemis Medicare Services Ltd. include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., and Sai Parenteral's Ltd., among others in the healthcare sector. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Sai Parenteral's Ltd.
What is the sector context for Artemis Medicare Services Ltd.?
Ans. Artemis Medicare Services Ltd. operates in the healthcare sector, which includes 198 companies, with varying P/E, P/B, ROE, and ROCE benchmarks. The stock belongs to the Healthcare sector. 198 comparable companies were included in the benchmark.
